Table: Hisamitsu - 9-MTH group results
Jan 6 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Nov 30, 2025 Nov 30, 2024 Feb 28, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 114.51 111.25
(+2.9 pct) (+8.2 pct)
Operating 12.61 13.22
(-4.6 pct) (+8.0 pct)
Recurring 16.63 16.47
(+1.0 pct) (-1.0 pct)
Net 11.89 13.66
(-13.0 pct) (+13.0 pct)
EPS 165.77 yen 185.02 yen
EPS Diluted 165.57 yen 184.76 yen
Ann Div 90.00 yen 60.00 yen
-Q2 div 60.00 yen 45.00 yen
-Q4 div 45.00 yen NIL
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO